Clinical trial
A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected…
NCT00001111 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001111 |
|---|---|
| Title | A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children |
| Official title | Pharmacokinetics, Safety, Tolerance, and Activity of Nevirapine (BI-RG-587) Alone and in Combination With AZT in Mildly to Moderately Symptomatic HIV-1 Infected Children |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Roxane Laboratories Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Nevirapine, Zidovudine |
| Enrollment | 35 |
| Primary completion | Jun 1, 1995 |
| First posted | Aug 31, 2001 |
| Last update posted | Mar 1, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: